Ambu A/S Logo

Ambu A/S

AMBU-B.CO

(0.5)
Stock Price

132,75 DKK

5.17% ROA

4.48% ROE

176.19x PER

Market Cap.

31.663.713.492,00 DKK

10.83% DER

0% Yield

4.86% NPM

Ambu A/S Stock Analysis

Ambu A/S Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Ambu A/S Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a low debt to equity ratio (14%), which means it has a small amount of debt compared to the ownership it holds

2 ROE

Negative ROE (-0.89%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

3 ROA

The stock's ROA (-1.27%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

4 PBV

The stock's high Price-to-Book Value (P/BV) ratio (4.65x) suggests it's overvalued, potentially making it an expensive investment.

5 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

6 Net Profit Growth

This company's net profit has remained flat over the past five years, suggesting a lack of growth and making it a less attractive investment opportunity.

7 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

8 Graham Number

The Graham number analysis indicates that this company's stock price is likely overpriced, raising concerns about its investment potential.

9 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

10 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

11 Buffet Intrinsic Value

The company's stock presents a potential concern as it appears overvalued (-10.805) by Warren Buffett's formula, indicating that its market price exceeds its estimated intrinsic value.

Ambu A/S Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Ambu A/S Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Ambu A/S Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Ambu A/S Revenue
Year Revenue Growth
2002 574.597.000
2003 566.806.000 -1.37%
2004 608.103.000 6.79%
2005 653.908.000 7%
2006 715.861.000 8.65%
2007 715.024.000 -0.12%
2008 784.445.000 8.85%
2009 876.931.000 10.55%
2010 939.688.000 6.68%
2011 982.812.000 4.39%
2012 1.045.457.000 5.99%
2013 1.383.000.000 24.41%
2014 1.584.000.000 12.69%
2015 1.889.000.000 16.15%
2016 2.084.000.000 9.36%
2017 2.355.000.000 11.51%
2018 2.606.000.000 9.63%
2019 2.820.000.000 7.59%
2020 3.567.000.000 20.94%
2021 4.013.000.000 11.11%
2022 4.444.000.000 9.7%
2023 5.036.000.000 11.76%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Ambu A/S Research and Development Expenses
Year Research and Development Expenses Growth
2002 14.431.000
2003 17.939.000 19.56%
2004 17.349.000 -3.4%
2005 0 0%
2006 27.168.000 100%
2007 26.862.000 -1.14%
2008 27.337.000 1.74%
2009 0 0%
2010 0 0%
2011 0 0%
2012 22.892.000 100%
2013 33.000.000 30.63%
2014 44.000.000 25%
2015 54.000.000 18.52%
2016 66.000.000 18.18%
2017 76.000.000 13.16%
2018 111.000.000 31.53%
2019 103.000.000 -7.77%
2020 157.000.000 34.39%
2021 225.000.000 30.22%
2022 281.000.000 19.93%
2023 328.000.000 14.33%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Ambu A/S General and Administrative Expenses
Year General and Administrative Expenses Growth
2002 90.963.000
2003 90.500.000 -0.51%
2004 93.409.000 3.11%
2005 105.473.000 11.44%
2006 -38.740.000 372.26%
2007 -30.883.000 -25.44%
2008 138.593.000 122.28%
2009 133.009.000 -4.2%
2010 149.970.000 11.31%
2011 152.679.000 1.77%
2012 154.563.000 1.22%
2013 192.000.000 19.5%
2014 205.000.000 6.34%
2015 239.000.000 14.23%
2016 221.000.000 -8.14%
2017 256.000.000 13.67%
2018 266.000.000 3.76%
2019 292.000.000 8.9%
2020 399.000.000 26.82%
2021 470.000.000 15.11%
2022 517.000.000 9.09%
2023 612.000.000 15.52%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Ambu A/S EBITDA
Year EBITDA Growth
2002 43.071.000
2003 60.682.000 29.02%
2004 56.666.000 -7.09%
2005 69.031.000 17.91%
2006 121.731.000 43.29%
2007 106.739.000 -14.05%
2008 -258.751.000 141.25%
2009 137.606.000 288.04%
2010 185.806.000 25.94%
2011 201.028.000 7.57%
2012 216.429.000 7.12%
2013 222.000.000 2.51%
2014 314.000.000 29.3%
2015 361.000.000 13.02%
2016 464.000.000 22.2%
2017 522.000.000 11.11%
2018 683.000.000 23.57%
2019 608.000.000 -12.34%
2020 579.000.000 -5.01%
2021 563.000.000 -2.84%
2022 495.000.000 -13.74%
2023 732.000.000 32.38%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Ambu A/S Gross Profit
Year Gross Profit Growth
2002 271.595.000
2003 281.179.000 3.41%
2004 305.228.000 7.88%
2005 340.937.000 10.47%
2006 367.351.000 7.19%
2007 374.119.000 1.81%
2008 419.432.000 10.8%
2009 460.589.000 8.94%
2010 510.487.000 9.77%
2011 545.975.000 6.5%
2012 575.707.000 5.16%
2013 679.000.000 15.21%
2014 798.000.000 14.91%
2015 916.000.000 12.88%
2016 1.124.000.000 18.51%
2017 1.331.000.000 15.55%
2018 1.547.000.000 13.96%
2019 1.637.000.000 5.5%
2020 2.212.000.000 25.99%
2021 2.503.000.000 11.63%
2022 2.554.000.000 2%
2023 2.860.000.000 10.7%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Ambu A/S Net Profit
Year Net Profit Growth
2002 14.986.000
2003 26.008.000 42.38%
2004 33.288.000 21.87%
2005 37.692.000 11.68%
2006 48.415.000 22.15%
2007 42.777.000 -13.18%
2008 50.011.000 14.46%
2009 55.764.000 10.32%
2010 84.055.000 33.66%
2011 69.213.000 -21.44%
2012 114.713.000 39.66%
2013 48.000.000 -138.99%
2014 151.000.000 68.21%
2015 152.000.000 0.66%
2016 250.000.000 39.2%
2017 301.000.000 16.94%
2018 337.000.000 10.68%
2019 317.000.000 -6.31%
2020 241.000.000 -31.54%
2021 247.000.000 2.43%
2022 93.000.000 -165.59%
2023 320.000.000 70.94%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Ambu A/S Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2002 0
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 1 0%
2015 1 0%
2016 1 100%
2017 1 0%
2018 1 0%
2019 1 0%
2020 1 0%
2021 1 0%
2022 0 0%
2023 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Ambu A/S Free Cashflow
Year Free Cashflow Growth
2002 -10.719.000
2003 7.815.000 237.16%
2004 54.766.000 85.73%
2005 -18.203.000 400.86%
2006 61.545.000 129.58%
2007 31.851.000 -93.23%
2008 35.586.000 10.5%
2009 57.415.000 38.02%
2010 31.036.000 -84.99%
2011 57.705.000 46.22%
2012 126.671.000 54.44%
2013 122.000.000 -3.83%
2014 172.000.000 29.07%
2015 208.000.000 17.31%
2016 310.000.000 32.9%
2017 462.000.000 32.9%
2018 552.000.000 16.3%
2019 272.000.000 -102.94%
2020 -135.000.000 301.48%
2021 -256.000.000 47.27%
2022 -463.000.000 44.71%
2023 188.000.000 346.28%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Ambu A/S Operating Cashflow
Year Operating Cashflow Growth
2002 25.530.000
2003 63.178.000 59.59%
2004 54.766.000 -15.36%
2005 40.126.000 -36.49%
2006 98.442.000 59.24%
2007 88.306.000 -11.48%
2008 84.465.000 -4.55%
2009 113.015.000 25.26%
2010 98.655.000 -14.56%
2011 102.071.000 3.35%
2012 157.625.000 35.24%
2013 122.000.000 -29.2%
2014 183.000.000 33.33%
2015 208.000.000 12.02%
2016 369.000.000 43.63%
2017 462.000.000 20.13%
2018 554.000.000 16.61%
2019 533.000.000 -3.94%
2020 295.000.000 -80.68%
2021 328.000.000 10.06%
2022 95.000.000 -245.26%
2023 273.000.000 65.2%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Ambu A/S Capital Expenditure
Year Capital Expenditure Growth
2002 36.249.000
2003 55.363.000 34.52%
2004 0 0%
2005 58.329.000 100%
2006 36.897.000 -58.09%
2007 56.455.000 34.64%
2008 48.879.000 -15.5%
2009 55.600.000 12.09%
2010 67.619.000 17.77%
2011 44.366.000 -52.41%
2012 30.954.000 -43.33%
2013 0 0%
2014 11.000.000 100%
2015 0 0%
2016 59.000.000 100%
2017 0 0%
2018 2.000.000 100%
2019 261.000.000 99.23%
2020 430.000.000 39.3%
2021 584.000.000 26.37%
2022 558.000.000 -4.66%
2023 85.000.000 -556.47%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Ambu A/S Equity
Year Equity Growth
2002 283.944.000
2003 294.117.000 3.46%
2004 320.139.000 8.13%
2005 349.142.000 8.31%
2006 391.068.000 10.72%
2007 418.179.000 6.48%
2008 452.012.000 7.48%
2009 479.621.000 5.76%
2010 561.596.000 14.6%
2011 579.857.000 3.15%
2012 678.105.000 14.49%
2013 667.000.000 -1.66%
2014 854.000.000 21.9%
2015 1.036.000.000 17.57%
2016 992.000.000 -4.44%
2017 1.279.000.000 22.44%
2018 1.882.000.000 32.04%
2019 2.182.000.000 13.75%
2020 2.372.000.000 8.01%
2021 3.952.000.000 39.98%
2022 4.261.000.000 7.25%
2023 5.393.000.000 20.99%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Ambu A/S Assets
Year Assets Growth
2002 563.199.000
2003 556.038.000 -1.29%
2004 591.108.000 5.93%
2005 658.007.000 10.17%
2006 677.735.000 2.91%
2007 680.773.000 0.45%
2008 732.223.000 7.03%
2009 781.664.000 6.33%
2010 875.871.000 10.76%
2011 889.156.000 1.49%
2012 965.508.000 7.91%
2013 1.891.000.000 48.94%
2014 2.047.000.000 7.62%
2015 2.254.000.000 9.18%
2016 2.366.000.000 4.73%
2017 2.500.000.000 5.36%
2018 4.234.000.000 40.95%
2019 4.558.000.000 7.11%
2020 4.926.000.000 7.47%
2021 5.740.000.000 14.18%
2022 7.215.000.000 20.44%
2023 6.859.000.000 -5.19%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Ambu A/S Liabilities
Year Liabilities Growth
2002 279.255.000
2003 261.921.000 -6.62%
2004 270.969.000 3.34%
2005 308.865.000 12.27%
2006 286.667.000 -7.74%
2007 262.594.000 -9.17%
2008 280.211.000 6.29%
2009 302.043.000 7.23%
2010 314.275.000 3.89%
2011 309.299.000 -1.61%
2012 287.403.000 -7.62%
2013 1.224.000.000 76.52%
2014 1.193.000.000 -2.6%
2015 1.218.000.000 2.05%
2016 1.374.000.000 11.35%
2017 1.221.000.000 -12.53%
2018 2.352.000.000 48.09%
2019 2.376.000.000 1.01%
2020 2.554.000.000 6.97%
2021 1.788.000.000 -42.84%
2022 2.954.000.000 39.47%
2023 1.466.000.000 -101.5%

Ambu A/S Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
18.78
Net Income per Share
0.66
Price to Earning Ratio
176.19x
Price To Sales Ratio
6.63x
POCF Ratio
57.14
PFCF Ratio
164.92
Price to Book Ratio
5.49
EV to Sales
6.72
EV Over EBITDA
51.02
EV to Operating CashFlow
61.95
EV to FreeCashFlow
167.14
Earnings Yield
0.01
FreeCashFlow Yield
0.01
Market Cap
31,66 Bil.
Enterprise Value
32,09 Bil.
Graham Number
17.76
Graham NetNet
-3.36

Income Statement Metrics

Net Income per Share
0.66
Income Quality
3.08
ROE
0.03
Return On Assets
0.03
Return On Capital Employed
0.06
Net Income per EBT
0.79
EBT Per Ebit
0.84
Ebit per Revenue
0.07
Effective Tax Rate
0.21

Margins

Sales, General, & Administrative to Revenue
0.12
Research & Developement to Revenue
0.06
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.57
Operating Profit Margin
0.07
Pretax Profit Margin
0.06
Net Profit Margin
0.05

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
2.04
Free CashFlow per Share
0.76
Capex to Operating CashFlow
-0.63
Capex to Revenue
-0.07
Capex to Depreciation
-0.94
Return on Invested Capital
0.04
Return on Tangible Assets
0.05
Days Sales Outstanding
0
Days Payables Outstanding
63.55
Days of Inventory on Hand
160.55
Receivables Turnover
0
Payables Turnover
5.74
Inventory Turnover
2.27
Capex per Share
-1.28

Balance Sheet

Cash per Share
0,62
Book Value per Share
21,21
Tangible Book Value per Share
7.01
Shareholders Equity per Share
21.21
Interest Debt per Share
2.54
Debt to Equity
0.11
Debt to Assets
0.09
Net Debt to EBITDA
0.68
Current Ratio
2.13
Tangible Asset Value
1,78 Bil.
Net Current Asset Value
0,54 Bil.
Invested Capital
0.11
Working Capital
1,07 Bil.
Intangibles to Total Assets
0.53
Average Receivables
0,00 Bil.
Average Payables
0,36 Bil.
Average Inventory
946000000
Debt to Market Cap
0.02

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Ambu A/S Dividends
Year Dividends Growth
2005 2
2006 3 0%
2007 2 -100%
2008 2 0%
2009 2 0%
2010 3 50%
2011 2 0%
2012 3 33.33%
2013 1 -200%
2014 4 66.67%
2015 1 0%
2016 2 100%
2017 2 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%

Ambu A/S Profile

About Ambu A/S

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. It provides healthcare solutions in the fields of visualization, anesthesia, and patient monitoring and diagnostics. The company offers endoscopy products, such as bronchoscopes and monitors; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of ECG electrodes; and airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, CPR breathing barriers, video laryngoscopes, and training manikins. Ambu A/S was founded in 1937 and is headquartered in Ballerup, Denmark.

CEO
Ms. Britt Meelby Jensen
Employee
4.600
Address
Baltorpbakken 13
Ballerup, 2750

Ambu A/S Executives & BODs

Ambu A/S Executives & BODs
# Name Age
1 Rummana Hasan
Chief Marketing Officer
70
2 Mr. Henrik Skak Bender
Executive Vice President & Chief Financial Officer
70
3 Henrik Birk
Chief Operations Officer
70
4 Mr. Finn Mohring
Chief Technology Officer
70
5 Mikkel Trier Wagner
Director of Corporate Communications
70
6 Ms. Britt Meelby Jensen
Chief Executive Officer
70
7 Holger Hesse
Founder
70
8 Mr. Nicolai Thomsen
Director of Investor Relations & Strategic Financial Planning
70
9 Mr. Thomas Lykke Henriksen
Head of HR Systems
70
10 Mr. Måns Barsne
Executive Vice President of Global Innovation & Chief Innovation Officer
70

Ambu A/S Competitors

Bavarian Nordic A/S Logo
Bavarian Nordic A/S

BAVA.CO

(3.0)
Genmab A/S Logo
Genmab A/S

GMAB.CO

(2.2)
GN Store Nord A/S Logo
GN Store Nord A/S

GN.CO

(1.2)
DSV A/S Logo
DSV A/S

DSV.CO

(2.0)
FLSmidth & Co. A/S Logo
FLSmidth & Co. A/S

FLS.CO

(2.5)